埃维纳库马布改善了同卵性家族高胆固醇血清症的脂质代谢:一个案例报告
Takaaki Matsuda1,2, Yoshinori Osaki3, Nako Matsumoto1
1Department of Endocrinology and Metabolism, University of Tsukuba Hospital.
Journal of atherosclerosis and thrombosis
|October 8, 2025
概括
在一个患有家族性高胆固醇血症的日本患者中,埃维纳库马布显著降低了LDL-C和甘油三. 治疗还改善了动脉样硬化标志物和阿波利波蛋白,这表明除了降低LDL-C之外还有更广泛的心血管益处.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 家庭性高胆固醇血症 (FH) 涉及高的LDL-C和早期动脉样硬化风险.
- 埃维纳库马布抑制ANGPTL3,降低LDL-C独立于LDL受体.
- 关于埃维纳库马布对各种脂质标记物的影响的现实数据有限.
研究的目的:
- 评估埃维纳库马布在患有FH的日本患者身上具有全面的脂质修饰作用.
- 在现实环境中评估埃维纳库马布对动脉样硬化相关标记物和阿波利波蛋白的影响.
主要方法:
- 一个54岁的日本妇女的病例报告,她患有复合异合体FH.
- 与其他降脂剂和脂质蛋白非结合使用埃维纳库马布的治疗.
- 在开始使用埃维纳库马布之前和之后,分析血清脂质样本和动脉样硬化标志物.
主要成果:
- 埃维纳库马布可以将LDL-C降低36.7%,而甘油三水平则降低66.8%.
- 观察到残留样颗粒胆固醇 (RLP-C),小密度的LDL-C (sdLDL-C) 和样醇修饰的LDL (MDA-LDL) 的显著降低.
- 观察到阿波利波蛋白 (ApoB,ApoC2,ApoC3,ApoE,ApoA5) 的降低,而脂蛋白 (a) 或炎症标志物没有显著变化.
结论:
- 埃维纳库马布在改善日本FH患者的脂质样本和动脉样硬化标志物方面表现出高效.
- 药物的益处超出了减少LDL-C的范围,可能提供额外的心血管保护.
- 研究结果提供了关于治疗FH和相关脂质失调症的治疗策略的见解.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Lipid Absorption
2.4K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.4K
Lipid Catabolism
850
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
850
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Lipid Digestion
98.7K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
98.7K
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K


